Debt and the Demographics of Aging

Greece’s recent fiscal meltdown wasn’t caused just by carefree government spending. It was an inevitable result of the country’s aging population, which has long been accustomed to extravagant health care and retirement benefits. This is what happens when 19th-century policy prescriptions are applied to 21st-century realities.

That’s why the most recent European bailout package is only a short-term remedy to the complex issue of global aging. For decades, Europe has built a health-and-welfare system designed around providing support to its citizens at what in an earlier time might have been the very first signs of senior citizenship. Greeks are eligible for government pensions at age 53. The problem will only get worse. Over the next 40 years, a third of Europeans will be older than 60. The debt crisis is really just a proxy for the aging crisis that is coming to every country in the world.

Indeed, the global scope of the graying demographics are well known – and irreversible. Like Europe, Japan and Korea will by midcentury have 40 percent of their populations older than 60. In China, at least a quarter of the population will be elderly. In the United States, the number of citizens older than 65 will double during the next 20 years. These demographic trends will define our social and economic needs and government policy for decades. It requires a radical new way of thinking, which includes a 21st-century approach to policies that align with the longevity revolution begun in the latter part of the 20th century.

The implications are dizzying. Asian countries will have to import health workers to care for their elderly. Public pension plans will have to be re-examined to account for the millions of workers who will need retirement funds even as they continue to work into their 70s. The number of Alzheimer’s patients is expected to double every two decades, affecting more than 115 million people by 2050. The incidence of other age-related diseases, such as skin cancer, also will soar. And as longevity extends, insurance and retirement savings plans will need to be reconceived as bulging populations need to stretch benefits for longer periods of time.

Last week, President Obama established a bipartisan “debt commission.” Instead of looking at the usual combination of tax increases and spending-cut triggers, this commission ought to lead a conversation about a new approach to aging that will shape the political economy. That conversation should include policies to keep people healthy as they age, but also how we approach work, retirement planning, labor supplies and technology.

There is solid evidence that aging can be treated as an unprecedented opportunity for investment in economic growth. Economists David E. Bloom and David Canning have found that nations that have a five-year advantage in life expectancy have a 0.5 percent faster economic growth rate.

Business and government leaders ought to seize this insight to make the case for a far more enterprising, innovation-based and growth-focused approach to issues of retirement planning, workplace and the treatment of long-term illness.

The workplace is an obvious starting point. Almost all government pension plans, and most private ones, still operate on obsolete assumptions that people stop working in their mid-60s and die soon after. For the 21st century, all G-20 countries need policies aligned with the transformation that aging populations represent – on retirement planning, financial literacy and workplace “healthy aging.” Our new middle age can become an engine of productivity, not a cohort of dependence.

The treatment of age-related health conditions will also require policy shifts, just as we have shifted with communicable diseases. France, the United Kingdom, Australia, Sweden, Norway and Japan already have national Alzheimer’s plans in place, as do a handful of states here. But to find treatments that reverse the effects of this disease and make progress on care and early detection will require massive, global public-funding commitments.

This fall at the G-20 meeting, our government leaders surely will address the debt crisis. But instead of looking at it only as a short-term fiscal challenge, they ought to use the occasion to introduce a “call to action on aging.” Incentives for innovative technology solutions for long-term care, transformational thinking about work and retirement planning and a global fund for age-related diseases such as Alzheimer’s might be good places to start.

The alarm bells over Greece ought to be a wake-up call for creative and innovative policy changes that will turn this demographic reality into a platform for wealth creation, innovation and even greater prosperity.

Dr. Robert N. Butler is president and chief executive of the International Longevity Center and received the 1976 Pulitzer Prize for “Why Survive? Being Old in America” (Johns Hopkins University Press, 2002). Michael W. Hodin is adjunct senior fellow at the Council on Foreign Relations and executive director for the Global Coalition on Aging: Health, Work, Financial Security.

Source: The Washington Times

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.